Muteins of human tear lipocalin
US7893208B2 · kind B2 · utility
5Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 2009 |
| Grant date | Feb 22, 2011 |
| Priority date | — |
| Expiry date | Aug 19, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel muteins derived from tear lipocalin or a homologue thereof. In particular, the invention relates to a mutein of human tear lipocalin. The invention also refers to a corresponding nucleic acid molecule encoding such a mutein and to a method for its generation. The invention further refers to a method for producing such a mutein. Finally, the invention is directed to a pharmaceutical composition comprising such a lipocalin mutein as well as to various use of the mutein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.